News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
300,204 Results
Type
Article (10694)
Company Profile (110)
Press Release (289400)
Section
Business (89791)
Career Advice (481)
Deals (17934)
Drug Delivery (35)
Drug Development (44995)
Employer Resources (39)
FDA (7083)
Job Trends (6587)
News (160442)
Policy (13691)
Tag
Academia (779)
Alliances (21986)
Alzheimer's disease (642)
Approvals (7045)
Artificial intelligence (60)
Bankruptcy (160)
Best Places to Work (5728)
Biotechnology (102)
Breast cancer (64)
Cancer (620)
Career advice (432)
CAR-T (39)
Cell therapy (144)
Clinical research (36279)
Collaboration (194)
Compensation (58)
COVID-19 (974)
C-suite (61)
Data (696)
Diabetes (71)
Diagnostics (2636)
Earnings (38078)
Events (46688)
Executive appointments (151)
FDA (7368)
Funding (168)
Gene therapy (88)
GLP-1 (210)
Government (1455)
Healthcare (6957)
Infectious disease (1016)
Inflammatory bowel disease (68)
Interviews (58)
IPO (9243)
Job creations (1112)
Job search strategy (386)
Layoffs (64)
Legal (2526)
Lung cancer (78)
Manufacturing (87)
Medical device (4764)
Medtech (4765)
Mergers & acquisitions (8787)
Metabolic disorders (183)
Neuroscience (765)
NextGen Class of 2024 (2129)
Non-profit (942)
Northern California (860)
Obesity (103)
Opinion (92)
Patents (60)
People (25360)
Phase I (12090)
Phase II (16288)
Phase III (11310)
Pipeline (256)
Policy (40)
Postmarket research (911)
Preclinical (4678)
Press Release (53)
Radiopharmaceuticals (149)
Rare diseases (97)
Real estate (2172)
Regulatory (10254)
Research institute (724)
Resumes & cover letters (59)
Southern California (776)
Startups (1448)
United States (7285)
Vaccines (153)
Weight loss (69)
Date
Today (68)
Last 7 days (645)
Last 30 days (2081)
Last 365 days (21428)
2024 (18990)
2023 (23912)
2022 (28455)
2021 (30539)
2020 (27288)
2019 (18611)
2018 (14033)
2017 (15308)
2016 (13462)
2015 (16131)
2014 (11601)
2013 (8882)
2012 (9337)
2011 (10306)
2010 (9496)
Location
Africa (285)
Arizona (45)
Asia (21934)
Australia (5314)
California (1894)
Canada (815)
China (135)
Colorado (57)
Connecticut (87)
Europe (39340)
Florida (225)
Georgia (44)
Illinois (169)
Indiana (116)
Japan (43)
Maryland (252)
Massachusetts (1452)
Michigan (75)
Minnesota (100)
New Jersey (624)
New York (563)
North Carolina (352)
Northern California (860)
Ohio (55)
Pennsylvania (491)
South America (459)
Southern California (776)
Texas (243)
Washington State (283)
300,204 Results for "arcis biotechnology limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dynavax Adopts Limited-Duration Stockholder Rights Plan
October 30, 2024
·
5 min read
Layoffs
Sana Biotechnology Will Lay Off Employees as It Shifts Pipeline
About a year after cutting staff by 29%, Sana Biotechnology will trim its workforce as it increases investment in its type 1 diabetes program and looks to extend its cash runway.
November 5, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Catalyzing the Future of Biotechnology Talent
November 1, 2024
·
3 min read
Drug Development
IMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placebo
Positive results from the ADRIATIC Phase III trial showed AstraZeneca’s IMFINZI® demonstrated statistically significant and clinically meaningful improvements in the dual primary endpoints of overall survival and progression-free survival compared to placebo for patients with limited-stage small cell lung cancer who had not progressed following standard-of-care concurrent chemoradiotherapy.
June 2, 2024
·
27 min read
Press Releases
Tempest Extends Limited Duration Stockholder Rights Plan
October 11, 2024
·
6 min read
Press Releases
Gelteq Limited Closes US$5.2 Million Initial Public Offering
October 31, 2024
·
2 min read
Press Releases
Gelteq Limited Prices US$5.2 Million Initial Public Offering
October 29, 2024
·
3 min read
Genetown
Bionomics Limited Announces Private Placement of up to $70.0 Million
Bionomics Limited announced it has entered into a securities purchase agreement with an institutional accredited investor to purchase American Depository Shares and accompanying warrants in a three-tranche private placement.
May 31, 2024
·
7 min read
Press Releases
Bionomics Limited announces intention to re-domicile to the United States
October 1, 2024
·
9 min read
Press Releases
Nautilus Biotechnology Reports Third Quarter 2024 Financial Results
October 29, 2024
·
8 min read
1 of 30,021
Next
